Healthcare professionals and consumers can report using paper, telephone or e-mail but in many countries web-based system or specific Apps for smartphone are available for the purpose. The recent European law on Pharmacovigilance (PV) requires National PV Centres to setup web-based systems for reporting. In Italy ADRs reporting via web is now possible thanks to the collaboration between the Italian Medicines Agency (AIFA) and the University of Verona, where the Regional Pharmacovigilance Centre of Veneto region is located. The new web-reporting platform is called VigiFarmaco (www.vigifarmaco.it). This study aims to verify the impact of its implementation on underreporting in Italy
Background: Patients are important stakeholders in pharmacovigilance; however, little formal evaluat...
Background: The reporting of adverse drug reactions (ADRs) is the mainstay of post-marketing surveil...
The recent EU regulation on Pharmacovigilance [Regulation (EU) 1235/2010, Directive 2010/84/EU] impo...
Introduction: Spontaneous reporting of adverse drug reactions (ADRs) is the basis of pharmacovigilan...
<p><b>Background</b>: The number of suspected adverse drug reactions (ADRs) yearly submitted to the ...
Objective: To describe the evolution of adverse drug reactions (ADRs) spontaneously reporting in the...
none6Spontaneous reporting system of adverse drug reactions (ADR) represents the cornerstone of the ...
Background. In France, online reporting via a website is a new method for notifying advers...
OBJECTIVE: Adverse drug reaction (ADR) reporting by patients has a fundamental role in pharmacovigi...
Background: Spontaneous reporting of suspected adverse drug reactions (ADR) is considered the eorner...
Adding patients to the range of potential reporters of adverse drug reactions (ADRs) may increase sp...
Our aim was to investigate the ADR reports of drugs with a monitoring registry (MR drugs), in partic...
Purpose Natural health products are promoted to the public as equally or more effective and less tox...
Purpose The aim of this study was to describe the pattern of adverse drug reaction (ADR) reports sen...
PURPOSE: Underreporting is a major limitation of spontaneous reporting systems for suspected adve...
Background: Patients are important stakeholders in pharmacovigilance; however, little formal evaluat...
Background: The reporting of adverse drug reactions (ADRs) is the mainstay of post-marketing surveil...
The recent EU regulation on Pharmacovigilance [Regulation (EU) 1235/2010, Directive 2010/84/EU] impo...
Introduction: Spontaneous reporting of adverse drug reactions (ADRs) is the basis of pharmacovigilan...
<p><b>Background</b>: The number of suspected adverse drug reactions (ADRs) yearly submitted to the ...
Objective: To describe the evolution of adverse drug reactions (ADRs) spontaneously reporting in the...
none6Spontaneous reporting system of adverse drug reactions (ADR) represents the cornerstone of the ...
Background. In France, online reporting via a website is a new method for notifying advers...
OBJECTIVE: Adverse drug reaction (ADR) reporting by patients has a fundamental role in pharmacovigi...
Background: Spontaneous reporting of suspected adverse drug reactions (ADR) is considered the eorner...
Adding patients to the range of potential reporters of adverse drug reactions (ADRs) may increase sp...
Our aim was to investigate the ADR reports of drugs with a monitoring registry (MR drugs), in partic...
Purpose Natural health products are promoted to the public as equally or more effective and less tox...
Purpose The aim of this study was to describe the pattern of adverse drug reaction (ADR) reports sen...
PURPOSE: Underreporting is a major limitation of spontaneous reporting systems for suspected adve...
Background: Patients are important stakeholders in pharmacovigilance; however, little formal evaluat...
Background: The reporting of adverse drug reactions (ADRs) is the mainstay of post-marketing surveil...
The recent EU regulation on Pharmacovigilance [Regulation (EU) 1235/2010, Directive 2010/84/EU] impo...